Vivalyx is dedicated to solving the global organ shortage. This shortage in donor organs costs millions of lives and billions of dollars. However, it is solvable by perfusing organs at body temperature: a method clinically proven but hardly scalable due to reliance on rare donor blood and its high costs. Vivalyx introduces a patented solution surpassing this barrier for the first time, making perfusion at body temperature scalable. Their novel liquid Vivalyx Omnisol outperforms the efficacy of the blood-based benchmark in preclinical trials, is fully synthetic – eliminating blood-related concerns – and significantly cuts costs. Moreover, Vivalyx Omnisol is a one-stop-solution for all preservation methods: body temperature perfusion, cold perfusion, and static cold storage; with expected beneficial clinical outcomes.